Lounis H, Mes-Masson A M, Dion F, Bradley W E, Seymour R J, Provencher D, Tonin P N
CHUM-Campus Notre-Dame/Institut du cancer de Montréal, Québec, Canada.
Oncogene. 1998 Nov 5;17(18):2359-65. doi: 10.1038/sj.onc.1202152.
Epithelial ovarian tumors frequently display deletions on the short arm of chromosome 3 suggesting the existence of tumor suppressor genes within the deleted regions. We have recently established a primary tissue culture system as a model to investigate the genetic events associated with ovarian cancer. The frequencies of loss of heterozygosity (LOH) at 16 loci representative of chromosome 3p in 33 tumor biopsies and 47 ovarian primary cultures derived from unselected ovarian cancers were examined. This repertoire also included benign and borderline tumors as well as malignant ovarian ascites. LOH was observed in 25 (31%) samples for at least one marker: 21 of 58 malignant, two of 12 borderline and two of 10 benign specimens. Chromosome 3p loss was not restricted to ovarian tumors of high grade and stage. LOH was observed in both cultured and non cultured tumors and ascites. A spontaneously immortalized cell line derived from a malignant ovarian ascites, OV-90, displayed LOH of the majority of markers suggesting loss of one homolog of chromosome 3p. The pattern of deletion displayed by these 25 samples enabled the determination of at least two distinct regions of overlapping deletions on chromosome 3p extending from D3S1270 to D3S1597 and from D3S1293 to D3S1283. In addition, a region proximal to D3S1300 was deleted in a subset of samples. Although loss of loci overlapping these three regions (Regions I, II and III) were observed in malignant and benign tumors, in borderline tumors loss was observed of markers representative of Region III only. While RARbeta is presently included in Region II, the minimal regions of deletion exclude VHL, TGFBR2, PTPase(gamma) and FHIT as candidate tumor suppressors in ovarian tumorigenesis.
上皮性卵巢肿瘤常常在3号染色体短臂上出现缺失,这表明在缺失区域内存在肿瘤抑制基因。我们最近建立了一个原代组织培养系统作为模型,以研究与卵巢癌相关的遗传事件。检测了33例肿瘤活检样本和47例源自未经选择的卵巢癌的卵巢原代培养物中代表3号染色体短臂的16个位点的杂合性缺失(LOH)频率。这个样本库还包括良性和交界性肿瘤以及恶性卵巢腹水。在25个(31%)样本中至少观察到一个标记的LOH:58例恶性样本中有21例,12例交界性样本中有2例,10例良性样本中有2例。3号染色体短臂缺失并不局限于高级别和晚期卵巢肿瘤。在培养的和未培养的肿瘤及腹水中均观察到LOH。一个源自恶性卵巢腹水的自发永生化细胞系OV-90显示出大多数标记的LOH,提示3号染色体短臂的一个同源物缺失。这25个样本显示的缺失模式使得能够确定3号染色体短臂上至少两个不同的重叠缺失区域,从D3S1270延伸至D3S1597以及从D3S1293延伸至D3S1283。此外,在一部分样本中,D3S1300近端的一个区域缺失。尽管在恶性和良性肿瘤中均观察到与这三个区域(区域I、II和III)重叠的位点缺失,但在交界性肿瘤中仅观察到代表区域III的标记缺失。虽然视黄酸受体β(RARβ)目前包含在区域II中,但最小缺失区域排除了VHL、转化生长因子β受体2(TGFBR2)、蛋白酪氨酸磷酸酶(γ)(PTPase(γ))和脆性组氨酸三联体基因(FHIT)作为卵巢肿瘤发生中的候选肿瘤抑制基因。